Form 4: Stem Inc. Executive Kim Homenock Reports Acquisition of 100,000 Restricted Stock Units
SEC Form 4 Filing
Kim Homenock, Chief People Officer of Stem Inc., reports the acquisition of 100,000 Restricted Stock Units (RSUs) on May 28, 2024, according to a Form 4 filing with the SEC.
Summary
- On May 28, 2024, Kim Homenock, Chief People Officer of Stem Inc., filed a Form 4 with the SEC.
- The filing reports the acquisition of 100,000 Restricted Stock Units (RSUs).
- These RSUs vest in three annual installments starting March 7, 2025 (33%/33%/34%).
- Following the reported transaction, Homenock directly owns 179,221 shares of Stem Inc.
- The transaction was signed by Chen Zhang, attorney-in-fact, on May 28, 2024.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard executive compensation disclosure. The acquisition of RSUs can be seen as a positive sign of confidence, but it's a routine event.
Positives
- The acquisition of RSUs by a company executive can be seen as a positive sign, indicating confidence in the company's future performance.
Future Outlook
The vesting schedule of the RSUs suggests a multi-year commitment from the executive.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency regarding insider transactions in publicly traded companies.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment due to the executive's increased stake in the company.
Key Dates
| Date | Description |
|---|---|
| 05/28/2024 | Date of transaction and filing of Form 4. |
| 03/07/2025 | First vesting date for the Restricted Stock Units (33%). |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.